Objective: The objective of this article was to study the effect of antenatal dexamethasone on the respiratory morbidity of late preterm newborns. Study design: A randomized controlled trial, conducted in Obstetrics and Gynecology Department in collaboration with Neonatology department at JIPMER, India. In total, 155 women were studied in each group. Intention to treat analysis and per protocol analysis were done. Results: Overall 31 (10%) newborns were admitted to intensive care unit. The composite respiratory morbidity (defined as respiratory distress syndrome and/or transient tachypnea of newborn) was observed in 64 (41.6%) infants in the study and 56 (36.2%) infants in the control group. On multivariable-adjusted analysis, use of steroids was not found to be associated with decrease in composite respiratory morbidity [adjusted relative risk 0.91 (95% confidence interval: 0.7-1.2)]. Conclusions: Antenatal dexamethasone does not reduce the composite respiratory morbidity of babies born vaginally or by emergency cesarean to women with late preterm labor.
I N T R O D U C T I O N
Worldwide prevalence of preterm birth is 9.6%. More than 1 million preterm newborns die each year [1] . In a retrospective cohort study of 18 years, the authors found that late preterm deliveries complicate 9% of all deliveries, and further, three-fourth of all preterm deliveries are late preterm [2] . India has a high preterm birth rate with an incidence of around 13.0% [3] . In a recent study from India, late preterm deliveries were found to be 14% of all deliveries [4] . Late preterm infants (those between 34 and 36þ6/7 weeks of gestation) face a significantly greater risk of adverse respiratory outcomes compared with term infants [5] [6] [7] .
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There are few completed trials addressing the effect of ACS on the late preterm newborns [10] . Balci and colleagues [11] found ACS to be beneficial, but their sample size was small, and nearly one-third of women in both the groups had been delivered by scheduled cesarean section. Porto and colleagues [12] , on the other hand, did not find any benefit of antenatal betamethasone on transient tachypnea or respiratory distress syndrome among the late preterm newborns.
This randomized controlled trial (RCT) was undertaken to study the effect of antenatal dexamethasone on composite respiratory morbidity among the late preterm babies born vaginally or by emergency cesarean section to women with preterm labor.
M A T E R I A L A N D M E T H O D S
Trial design and study setup We conducted this RCT (parallel allocation with 1:1 ratio) in Obstetrics and Gynaecology Department in collaboration with the Department of Neonatology at the Jawaharlal Nehru Institute of Postgraduate Medical Education and Research (JIPMER) from February 2015 to June 2016. It is a tertiary care institute of National importance. It caters to the poor population free of cost. The institute ethics committee approved the study, and it is registered with the Clinical Trials Registry-India (Clinical Trials Registry-India: http://ctri.nic.in/Clinicaltrials/login. php CTRI no 2016/12/007570).
Screening and recruitment
We screened all women admitted to labor ward with the risk of late preterm delivery. We included women admitted to the labor room with a period of gestation between 34 and 36 þ 6 weeks with a singleton pregnancy with risk of preterm delivery either spontaneously or requiring termination for maternal (or) fetal indication. We calculated gestational age as per the last menstrual period or early pregnancy scan. Those who were far advanced in labor (5 cm or more dilated) or had received the previous course of steroids or had chorioamnionitis at admission were considered ineligible. We excluded women with multiple gestations, gestational diabetes and diabetes mellitus, major congenital malformations in the fetus and those undergoing a pre-labor scheduled cesarean section.
Randomization and intervention
Among the 1575 women screened, 1265 were either ineligible or excluded (Fig. 1) . After informing study details and obtaining informed consent, we randomized 310 eligible women into ACS group, and non-ACS group using computer-generated random numbers (generated and provided in a sequentially numbered, sealed, opaque envelopes, from an independent data coordinating party, from the Department of Preventive and Social Medicine). Women randomized to study group received four doses of dexamethasone (hospital supply given free of cost for patients), 6 mg administered intramuscularly 12 hourly. Control group did not receive steroids or placebo. We administered tocolytics and antibiotics as per the department protocol. There was no loss to follow-up after randomization. One case in the study group was excluded from analysis because it was stillborn.
Study outcomes
Structured pro forma was used to collect the data. The primary outcome measure was composite respiratory morbidities (transient tachypnea; respiratory distress syndrome). Transient tachypnea of the newborn was defined as the presence of clinical signs of respiratory distress at birth without any significant radiological changes or with a feature of hyperinflation/interlobar fluid that resolved within 72 h. Respiratory distress syndrome was defined as signs of respiratory distress at birth along with radiological evidence of decreased air entry of diffuse granular infiltrates. Other complications such as hypoglycemia, hypothermia, poor feeding, sepsis and neonatal mortality were also noted. We followed up all the babies until discharge from the hospital.
Sample size calculation
Based on the literature, the composite respiratory morbidity in the unexposed group is 25% [13] . A 50% reduction is expected with the intervention. So, for 80% power and an alpha error of 0.05, based on Kelsey and Fleiss continuity correction, a sample size of 155 was required in each group. Thus, we included 155 women in each group (total sample size of 310).
Analysis
The analysis was performed using SPSS version 19.0. Continuous variables were described using mean and SD as well as the median for gestational age and birth weight and compared with unpaired t-test or Wilcoxon rank sum (Mann-Whitney U) test. We compared categorical variables using chi-square test. We performed an intention to treat analysis for comparing the primary outcome. We calculated relative risk (RR) with 95% confidence intervals (CIs). A p-value of <0.05 was taken as statistically significant. To adjust for the baseline differences between the two groups, adjusted RRs with 95% CIs were calculated using log-binomial regression. Intention to treat analysis (irrespective of the number of doses of steroids) and per protocol analysis (including only those who received all four doses of steroids) were done.
R E S U L T S
In total, 155 women were randomly assigned to each group. In the study group, 108 women (70%) completed the full dexamethasone course before delivery (Fig. 1) .
None of the subjects in either group delivered after 37 weeks. Therefore, 154 in the study group and all 155 in the control group were analyzed. Most of the baseline characters (Table 1) were comparable in the two groups. However, a significant number of women in the study group underwent emergency cesarean section (p < 0.001). In our study, 5 of 155 (3.2%) in control and 4 of 154(2.6%) in steroid group had intrauterine growthretarded babies. This difference is not statistically significant (p-value ¼ 0.74), though the mean birth weight was significantly higher in the study group (p < 0.001). This s a statistical difference and is not of clinical significance (2.4 vs. 2.36 kg). We did not observe any serious side effect or short-term adverse effect of the steroid injection to the women. Table 2 shows the neonatal outcome. There was no statistical difference in the study and the control group for Apgar scores, admission to neonatal intensive care unit (NICU) and resuscitation steps. None of the babies who developed transient tachypnea required a bag and mask ventilation and intubation. Among those who developed respiratory distress syndrome, seven needed a bag and mask ventilation and four required intubation. The composite respiratory morbidity was maximum in the babies born between 34 and 34 þ 6 weeks compared with higher periods of gestation, though it was not of statistical significance. None of the babies among the two groups developed morbidities like hypoglycemia and hypothermia during the period of stay in the hospital.
In both unadjusted analysis and adjusted analysis, mode of delivery is associated with composite respiratory morbidity. We agree that emergency caesarean section numbers are high in the study group. However, this difference is taken care of/adjusted in the multivariable analysis, and the independent effect of steroids is estimated. In adjusted analysis 
D I S C U S S I O N
In this RCT, we found that there is no statistically significant difference in the Apgar score, NICU admission or steps of resuscitation in the two groups. Further, antenatal dexamethasone was not found to reduce respiratory morbidity (transient tachypnea of newborn of respiratory distress syndrome) in the babies born after late preterm labor. In the present study, though the mean birth weight of babies was significantly lower in the control group, the absolute difference was only 90 g. The strength of our study is that 68% of the study group received the complete course of steroids. We excluded the factors such as multiple gestations, maternal diabetes mellitus (gestational and pregestational), major congenital malformations in the fetus and pre-labor planned cesarean section that affect the respiratory morbidity in newborns. The attempt to administer all four doses probably significantly increased the mean interval from admission to delivery in the study group.
There have been four RCTs that were completed and published in English language and that have compared the effect of steroids on late preterm newborns. The study setup, primary outcomes, type of steroids and actual percentage of the primary outcome are summarized in Table 5 .
Balci et al. [11] found steroids to be beneficial in reducing respiratory distress at birth. However, the sample size was small. There was post-randomization exclusion of cases, and nearly one-third of the cases were scheduled planned cesarean section.
Porto and colleagues [12] did not observe any significant difference in the respiratory morbidity, transient tachypnea or respiratory distress syndrome among the steroid group. Total 78% had completed the steroid dose. However, 43 women (13%) were lost to follow-up.
In the trial by Attawattanakul and Tansupswatdikul [14] , though the authors observed significantly higher NICU admissions and respiratory distress (primary outcome) at birth in the control group, the rate of transient tachypnea and respiratory distress was comparable in the two groups. Further, only 6% of the study completed the course of steroids.
In the largest trial involving 17 centers, the authors [15] observed that steroids significantly reduced the respiratory problems. However, it is important to note that only 60% participants completed the full course of steroids. In their trial, 25% of those with the primary outcome and 32% of those with secondary outcome had planned elective cesarean deliveries. The role of steroids for preterm scheduled cesarean section is well established [16] [17] [18] [19] [20] .
Thus, though the largest trial [15] has concluded that steroids are beneficial in preventing respiratory problems, it is important to note that scheduled planned cesarean section was not excluded in this study. We excluded all planned cesarean section in our study and found that steroids could not improve the respiratory morbidity in the late preterm newborns. The limitation of our study is that we did not have a placebo group. Further, the enrolment and the allocation to the intervention were done by the same author, which could be a source of bias. Our study focused only on the respiratory morbidity. We did not study the other beneficial effects of steroids.
We conclude that administration of antenatal dexamethasone does not reduce the composite respiratory morbidity of babies born to women with late preterm labor and those who have not been delivered by scheduled cesarean section. We recommend more RCTs to study the effect of antenatal steroids on respiratory morbidity among newborns born late preterm labor excluding planned cesarean section and with the use of tocolysis and antibiotics as that would reflect the real-time scenarios before any changes in existing guidelines on this subject are considered. We also recommend studies to compare the impact of the rescue dose alone with that of a full course of antenatal steroids to women in late preterm labor on respiratory morbidity of newborns.
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